We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+17.1%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$72.5B
AUM Growth
+$8.64B
Cap. Flow
-$411M
Cap. Flow %
-0.57%
Top 10 Hldgs %
21.89%
Holding
3,099
New
114
Increased
2,324
Reduced
599
Closed
47

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$108M
2
MSFT icon
Microsoft
MSFT
+$73.2M
3
AMZN icon
Amazon
AMZN
+$49.5M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$27.8M
5
META icon
Meta Platforms (Facebook)
META
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.78%
2 Financials 13.46%
3 Healthcare 13.26%
4 Consumer Discretionary 12.31%
5 Communication Services 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLSS icon
3001
Milestone Scientific
MLSS
$42.6M
$62K ﹤0.01%
29,106
+5,302
+22% +$9.34K
AUO
3002
DELISTED
AU Optronics Corp
AUO
$59K ﹤0.01%
+11,952
New +$59K
NOK icon
3003
Nokia
NOK
$52.3B
$55K ﹤0.01%
14,115
+2,810
+25% +$11.1K
PAVM icon
3004
PAVmed
PAVM
$33.9M
$54K ﹤0.01%
57
+6
+12% +$5.13K
CBUS icon
3005
Cibus
CBUS
$138M
$53K ﹤0.01%
249
-73
-23% -$14.8K
AXLA
3006
DELISTED
Axcella Health Inc. Common Stock
AXLA
$53K ﹤0.01%
+406
New +$52.2K
REFR icon
3007
Research Frontiers
REFR
$17M
$52K ﹤0.01%
18,345
+1,950
+12% +$5.5K
ABEV icon
3008
Ambev
ABEV
$46.4B
$48K ﹤0.01%
15,798
SEAC
3009
DELISTED
Seachange International Inc
SEAC
$46K ﹤0.01%
1,625
+206
+15% +$3.58K
ATXS
3010
DELISTED
Astria Therapeutics
ATXS
$45K ﹤0.01%
3,524
+1,261
+56% +$22.5K
LNAI
3011
Lunai Bioworks
LNAI
$10.9M
$44K ﹤0.01%
187
+37
+25% +$9.35K
PR
3012
Permian Resources
PR
$16.9B
$41K ﹤0.01%
27,245
+3,644
+15% +$3.78K
ENIC icon
3013
Enel Chile
ENIC
$6.28B
$39K ﹤0.01%
10,035
MRKR icon
3014
Marker Therapeutics
MRKR
$18.7M
$37K ﹤0.01%
2,521
+334
+15% +$5.18K
BLRX
3015
BioLineRX
BLRX
$11.8M
$36K ﹤0.01%
+355
New +$31K
PHAS
3016
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$35K ﹤0.01%
+10,492
New +$37.6K
PANL icon
3017
Pangaea Logistics
PANL
$485M
$34K ﹤0.01%
+12,095
New +$34.1K
VERO
3018
DELISTED
Venus Concept
VERO
$28K ﹤0.01%
98
+17
+21% +$6.34K
CWBR
3019
DELISTED
CohBar, Inc. Common Stock
CWBR
$23K ﹤0.01%
569
+81
+17% +$2.74K
ALAR
3020
Alarum Technologies
ALAR
$14.3M
$15K ﹤0.01%
+1,073
New +$11.9K
CHGA
3021
Change Agents Corporation Common Stock
CHGA
$2.55M
$15K ﹤0.01%
90
+3
+3% +$534
GTE icon
3022
Gran Tierra Energy
GTE
$317M
$9K ﹤0.01%
2,435
MTL.PR
3023
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
$7K ﹤0.01%
13,618
AEG icon
3024
Aegon
AEG
$14.1B
-11,534
Closed -$27K
AYTU icon
3025
AYTU BioPharma
AYTU
$25.3M
-105
Closed -$25K

Similar funds

RhumbLine Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, RhumbLine Advisers held 3,099 positions worth $72.5B, up 14% from $63.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers's Q4 2020 filing shows 114 new, 2,324 increased, 599 reduced and 47 closed positions. Its largest new stake was Apartment Income REIT Corp.: 482,605 shares worth $18.5M. The largest sale was Apple, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2020 buy was Apartment Income REIT Corp.: 482,605 shares worth $18.5M.
  • RhumbLine Advisers added most to Tesla in Q4 2020, an estimated $278M increase.
  • RhumbLine Advisers's biggest Q4 2020 reduction was Apple, cutting an estimated $108M.
  • RhumbLine Advisers fully exited Immunomedics Inc in Q4 2020, selling an estimated $20.4M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $72.5B portfolio in Q4 2020.
  • RhumbLine Advisers opened 114 new positions and closed 47 in Q4 2020.
  • RhumbLine Advisers's portfolio value rose 14% quarter-over-quarter to $72.5B.

Based on RhumbLine Advisers's 13F filing for Q4 2020, filed 10 Feb 2021.